MYX2449

N/A

Report date: 2026/01/05 16:20:07

Base Information

Drug NameMYX2449

Drug Alias NameMYX-2449MYX2449

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker

Mechanisms of ActionPeptide N-myristoyltransferase 1 inhibitorsPeptide N-myristoyltransferase 2 inhibitorsAnti-HER2

TargetsPeptide N-myristoyltransferase 1Peptide N-myristoyltransferase 2Receptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMyricx Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesMyricx Pharma Ltd

Inactive CompaniesN/A

Active IndicationsStomach NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A